Primary care physicians Gary Ferenchick, Kate Rowland, Henry Barry and Mark Ebell want you to know about 4 new studies: the best choice of pharmacotherapy in hypertensive disorders of pregnancy, benefits and harms of intensive BP lowering, elinzanetant for therapy-induced vasomotor symptoms in women with breast cancer, and 23 year follow up of the European Prostate Cancer Screening Trial. Plus a confusing quiz question (thanks Gary!).

Links

Essential Evidence Plus: www.essentialevidenceplus.com

HTN in pregnancy: https://pubmed.ncbi.nlm.nih.gov/40216176/

Intensive BP lowering: https://pubmed.ncbi.nlm.nih.gov/40902616/

Elinzanetant for vasomotor symptoms in patients taking tamoxifen or anastrozole: https://pubmed.ncbi.nlm.nih.gov/40454634/

23 year follow-up of large European prostate cancer study: https://pubmed.ncbi.nlm.nih.gov/41160819/